Brazil Medical Council Bans Doctors From Using Injectable PMMA

Overview

• The Federal Council of Medicine issued Resolution No. 2.461/2026 that bars physicians from injecting PMMA for aesthetic or reparative uses, with the ban taking effect on Tuesday, June 2.
• The rule preserves a single exception for treating HIV‑associated lipodystrophy only in high‑complexity units accredited by the public health system and following Ministry of Health protocols.
• CFM leaders cited chronic inflammation, granulomas, material migration, hypercalcemia, kidney injury and reported deaths as the basis for the ban and warned that surgical removal of PMMA is often impossible or mutilating.
• CFM said it will seek a meeting with Anvisa to press for broader market restrictions while Anvisa maintains that the two PMMA fillers registered in Brazil are acceptable when used strictly for approved indications.
• The ban makes any physician use or promotion of PMMA a professional infraction, which could reduce legal medical use but may also shift risk toward unregulated providers or black‑market treatments and leave patients with existing PMMA facing long‑term care burdens.